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Introduction
One in nine elderly Australian men have symptoms or signs
of early peripheral arterial disease (Fowler et al 2002).
Once established, the natural history of this condition is
uncertain. Most of what is known about the management
and outcome of peripheral arterial disease is based on small
studies of patients with moderate to severe disease referred
for vascular surgical assessment. Housley et al (1988)
indicate that “stop smoking and keep walking” has long
been the standard first line of management, despite a
paucity of adequate studies showing benefits (Robeer et al
1998). Among less advanced cases, however, the risk of the
disease progressing to the point where operative
intervention is required is very small. Over the five years of
follow-up in the Edinburgh Artery Study, fewer than 9% of
affected individuals required surgical intervention (Leng et
al 1996). Indeed, the relative rarity of major endpoints in
peripheral arterial disease means that studies of early
disease would have to be very large, or employ
extraordinarily efficacious interventions, or both, to have
any chance of detecting and declaring significant an effect
of treatment on risk of amputation or other surgical
intervention.
Conversely, early peripheral arterial disease is associated
with several clinical indicators for which the frequency is
sufficiently high to allow an intervention study to be of
manageable size if these symptoms and signs are also
sensitive to intervention. Candidate endpoints for such a
study include the presence of intermittent claudication, the
maximum walking distance before onset of intermittent
claudication, and the ankle:brachial index of systolic blood
pressure.
Having ascertained the prevalence of peripheral arterial
disease in elderly men in Perth (Fowler et al 2002), we
conducted a randomised controlled trial of an intervention
regimen based on Housley’s dictum of “stop smoking and
keep walking”. To maximise the broader applicability of
our results, we undertook an effectiveness study and were
careful to employ interventions that could be delivered via
health services that already existed in the local community,
including physiotherapy and general medical services.
Methods
Background - cross sectional survey  The initial cross-
sectional survey of 7,987 men that determined the
prevalence of early peripheral arterial disease was part of a
population-based trial of ultrasound screening for
abdominal aortic aneurysm in Western Australia. Full
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details of that study have been published elsewhere
(Jamrozik et al 2000). Briefly, it set out to screen for
abdominal aortic aneurysms and peripheral arterial disease
in a random half of male residents of Perth who were aged
from 65 to 79 years in April 1997. Eligible men were
identified from electoral rolls, enrolment to vote being
compulsory for Australian citizens, and invited to the one
of five screening centres that was nearest to their home.
Screening for peripheral arterial disease was undertaken at
three of these locations. 
Identification of subjects with peripheral arterial disease
The identification of men with early peripheral arterial
disease was based on: 
• A classification of either definite intermittent
claudication or atypical intermittent claudication on
the Edinburgh Claudication Questionnaire (Leng et al
1992); or
• An ankle:brachial index of systolic blood pressure of
0.9 or less in either leg, indicating a reduced blood
flow to the lower limbs; or
• Clinical examination and diagnosis of peripheral
arterial disease for those men with diabetes who did
not meet either criterion (i) or (ii), or who had an
ankle:brachial index of systolic blood pressure of 1.2
or more, or leg pain.
At the screening clinic, each man was asked for written
consent to his participation in the research. Via a
questionnaire, he then provided details of his personal and
medical background and lifestyle. As part of the
questionnaire he completed the Edinburgh Claudication
Questionnaire (Leng and Fowkes 1992), an instrument that
has greater sensitivity and specificity for intermittent
claudication than the original Rose questionnaire (Rose et
al 1962) on which it is based. At two of the three clinics
each man was also examined for peripheral arterial disease
using the ankle:brachial index of systolic blood pressure
(Yao et al 1969), a widely used test that is sensitive and
specific for the identification of early peripheral arterial
disease (Bernstein and Fronek 1982).
Enrolment for the trial of intervention in early peripheral
arterial disease began at one centre in November 1996 and
continued simultaneously in two clinics until March 1998.
Randomisation into study groups Using a computer-
generated sequence to which the staff enrolling participants
were blinded, eligible men were randomised in strata
defined by aortic size (< 30mm, 30-39mm) and smoking
habits (current smoker or not), into usual care and
intervention groups.
Usual care group Men allocated to the usual care group
were told by a nurse at the screening clinic that, “the blood
flow to your feet and legs is lower than normal. This is not
uncommon for men of your age but there is presently no
evidence to suggest you should do anything about it at this
time”. Neither the ankle:brachial index of systolic blood
pressure, if measured, nor findings on the Edinburgh
Claudication Questionnaire were mentioned in letters to the
man or his general practitioner that set out the results of
screening for an abdominal aortic aneurysm.
Intervention group Allocation to the intervention group led
to the men being told that “your ankle:brachial index of
systolic blood pressure or Edinburgh Claudication
Questionnaire test showed a reduced blood flow to the
muscles in your leg or legs caused by partial blockage of
the arteries and this often results in pain on walking”. They
were provided with an educational package including
information on peripheral arterial disease, a brochure on
the community physiotherapy service, information on
cessation of smoking (where applicable), and a copy of the
letter from the clinic to their general practitioner, and were
advised to consult the general practitioner about
management of the problem. In a separate communication,
the general practitioner was sent a package of written
materials about cessation of smoking, notes on obtaining
optimal results from nicotine replacement products, and a
fact-sheet on peripheral arterial disease. In addition, the
general practitioner was asked to discuss cessation of
smoking with relevant patients and to refer each man with
early peripheral arterial disease to the community
physiotherapy service, having first checked him for
suitability to undertake additional physical activity.
The clinic staff also advised the community physiotherapy
service directly about each likely referral. The senior
physiotherapist then contacted each man in the intervention
group within approximately three weeks of his screening
examination. 
The objective of the exercise intervention was to increase
the level of physical activity undertaken by each man in the
intervention group. This exercise could be completed either
independently or through an organised program. To
facilitate compliance with the intervention, each man was
invited to attend the community physiotherapy service’s
mobility program for seniors - a community based exercise
program that has been offered by physiotherapists in the
Perth metropolitan area since 1979. Participants in the
intervention group of the randomised controlled trial had
the choice of attending a weekly mixed-gender group
session as part of the established program or a men-only
session introduced to support the present trial. As an
alternative to attending the mobility program for seniors,
the participant could follow a home-based program of
physical activity devised specifically for him by the senior
physiotherapist from the community physiotherapy service.
In addition, all men in the intervention group were advised
by the physiotherapist to walk for at least 30 minutes a day.
In certain cases, men were referred to hydrotherapy classes
or special exercise sessions for the disabled.
The mobility program for seniors program for peripheral
arterial disease consisted of a structured physical activity
intervention involving a weekly exercise group of 45
minutes supervised by an experienced community
physiotherapist. The session included a warm-up phase of
stretching the calf, hamstring and upper limb muscles,
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followed by 20 minutes of fast walking, usually to music,
and ending with a cool-down period. The participant was
encouraged to continue walking until intermittent
claudication forced him to stop. 
Follow-up Men in both study groups were followed up by
reply-paid postal questionnaire at two and 12 months after
enrolment with, in each case, up to two reminders to non-
respondents at intervals of three weeks. At each follow-up,
men were asked to complete the Edinburgh Claudication
Questionnaire and to estimate their maximum walking
distance before the onset of pain in the legs (less than 100
yards, 100-440 yards, more than 440 yards, or no pain on
walking). Other sections of the questionnaire concerned
current smoking habits, patterns of physical activity
(weekly frequency and duration of vigorous and non-
vigorous activity and of walking for fitness or recreation.
“Vigorous” exercise was defined as non-work activity that
made the man breathe harder or puff and pant, while “non-
vigorous” activity covered all other forms of exercise
including walking (National Heart Foundation 1991)). A
man was classified as “physically active” if he engaged in
either vigorous or non-vigorous exercise at least weekly.
Health-related quality of life was measured on a scale of 
-1.2 (worst) through 0 (dead) to 1.0 (best) using an
instrument devised by Rosser et al (1991).
To reduce any trend for men to give responses perceived as
being socially desirable, the letter accompanying each
questionnaire used the logo of another local university and
the funding body and the text made no reference to
peripheral arterial disease or to the “stop smoking and keep
walking” program. 
Statistical considerations In a pilot study undertaken to
assess sample size requirements, we recalled 181 men
approximately one year after enrolment for a re-assessment
that included the Edinburgh Claudication Questionnaire,
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Table 1. Comparison of characteristics of study groups at
enrolment. Except where otherwise specified, data are
percentages. P-values are from t-test (age), Mann-
Whitney U test (body mass index, systolic blood pressure,
ABI) or chi-square test (all other variables).
Usual care Intervention p
n = 441 n = 441
% %
Age (mean years) 73.1 73.1 0.96
Intermittent claudication * 0.68
No pain on walking 27.9 26.8
Definite IC (Grade 2) 21.1 20.0
Definite IC (Grade 1) 22.4 25.6
Atypical IC (Grade 2) 3.4 2.9
Atypical IC (Grade 1) 7.1 5.1
Pain on walking  
(not vascular) 18.1 19.8
Maximum walking 
distance 0.51
Less than 100 yards 11.0 10.3
100 to 440 yards 24.8 21.7
Greater than 
440 yards 36.2 41.0
Pain-free walking 28.0 27.0
Smoking status
Current smoker 18.1 19.3 0.67
Body mass index 
(mean kg/m2) 26.5 26.4 0.44
Systolic blood pressure 
(mean mm Hg) 159.8 161.4 0.57
Diastolic blood pressure
(mean mm Hg) 86.6 87.2 0.57
ABI (mean, ratio) 0.79 0.79 0.89
Physical activity for 
recreation, sport or 
fitness less than weekly 31.6 28.6 0.34
Medical history
Diabetes mellitus 19.7 14.6 0.06
Angina 34.6 30.2 0.20
Myocardial infarction 25.3 22.6 0.40
Stroke 12.5 13.2 0.76
* Categories taken from the Edinburgh Claudication
Questionnaire.
ABI, ankle:brachial index. IC, intermittent claudication.
Table 2. Details of response to follow-up. Data are counts
except where specified.
Two months 12 months *
Usual Inter- Usual Inter-
care vention care vention
Eligible 441 441 437 432
Return to sender 1 1 5 5
Dead 3 4 21 14
Too ill to respond 1 0 4 0
Inadvertently not sent 
a questionnaire 10 7 0 0
Adjusted denominator 426 429 407 413
Completed and 
returned questionnaire 348 378 336 361
Returned questionnaire 
blank 31 26 27 19
Withdrew from study 1 5 9 7
No response 46 20 35 26
Crude response** 78.9% 85.7% 76.7% 83.4%
Adjusted response***81.7% 88.1% 82.6% 87.4%
*  Men who withdrew or had died at two months follow-up
have been omitted from eligibility at 12 months.
**  Completed questionnaires as a proportion of those
eligible. ***  Calculated using adjusted denominators.
maximum walking distance and the ankle:brachial index of
systolic blood pressure. Of the 123 (74%) of available men
who attended, 62 also undertook a 6min timed walking test
(Montgomery and Gardner 1998) to validate the self-
reported maximum walking distance. Examination of the
between-group differences indicated that to have an 80%
chance of declaring the impact of the intervention
significant, using a two-sided α = 0.05, the study would
have to enrol 2,400 men if the endpoint chosen was the
ankle:brachial index of systolic blood pressure (δ = 0.027)
and 20,400 men if the primary endpoint was the prevalence
of intermittent claudication (δ = 1.6%). However, 882 men
randomised into two groups of equal size would yield 90%
power for declaring significant (α = 0.05) a between-group
difference of 7.9% in the proportion of men able to walk
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Table 3. Comparison of study groups at follow-up at two
months. Data are percentages except where indicated
otherwise.
Usual care Intervention p
Status of men who 
smoked at enrolment * n = 79 n = 85
Stopped smoking 1.3 3.5 0.62
Current smoker 98.7 95.3
Physical activity n = 325 n = 353
Walking for 
recreation (≥ 3/week) 31.4 36.8 0.14
Vigorous activity 
(≥ 1/week) 31.1 29.9 0.73
More activity than 
usual 9.0 10.2 0.62
Membership of an 
exercise group 10.1 14.0 0.08
Maximum walking 
distance # n = 432 n = 433 0.81
Better 21.8 20.3
Same 52.5 52.4
Worse 25.7 27.3
Maximum walking 
distance ## n = 323 n = 339 0.63
Better 29.1 26.0
Same 36.5 39.2
Worse 34.4 34.8
Health-related quality 
of life 0.85 0.83 0.33
[mean (SD)] (0.14) (0.16)
*  Men who were alive but lost to follow-up were assumed
to have continued smoking.
#  Includes all those alive at 2 months, with men who did
not respond to follow-up included as having the same
maximum walking distance as at baseline
##  Limited to those alive at 2 months who responded
Table 4. Comparison of study groups at follow-up at twelve
months. Data are percentages except where indicated
otherwise. P-values are from t-test (health-related quality of
life) or chi-square tests (all other variables).
Usual Intervention p
care % %
Status of men who 
smoked at enrolment * n = 77 n = 82
Stopped smoking 7.8 12.2 0.43
Current smoker 92.2 87.8
Physical activity n = 328 n = 340
Walking for 
recreation 
(≥ 3 /week) 25.0 33.8 0.01
Vigorous activity 
(≥ 1/week) 35.3 38.5 0.39
More activity than 
usual 5.9 11.1 0.03
Membership of an 
exercise group 1.8 16.5 < 0.001
Maximum walking 
distance # n = 413 n = 419
Better 14.8 22.9 0.003
Same 68.5 59.9 0.01
Worse 16.7 17.2 0.84
Maximum walking 
distance ## n = 317 n = 347 0.04
Better 19.2 27.7
Same 59.0 51.6
Worse 21.8 20.7
Health-related 
quality of life 0.84 0.83 0.13
[mean (SD)] (0.14) (0.13)
Intermittent 
claudication** n = 327 n = 347 0.26
No pain on 
walking 37.0 40.9
Definite IC 
(Grade 2) 16.8 19.0
Definite IC 
(Grade 1) 14.1 9.5
Atypical IC 
(Grade 2) 2.8 1.2
Atypical IC 
(Grade 1) 1.2 0.9
Pain on walking 
(not vascular) 28.1 28.5
IC, intermittent claudication.
*  Men who were alive but lost to follow-up were assumed
to have continued smoking.
#  Includes all those alive at 12 months, with men who did
not respond to follow-up included as having the same
maximum walking distance as at baseline.
##  Limited to those alive at 12 months who responded.
**  Categories taken from the Edinburgh Claudication
Questionnaire.
100 to 400 yards before onset of intermittent claudication.
Moreover, the kappa statistic (Bland and Altman 1988)
summarising concordance between categories of self-
reported and measured maximum walking distance was
0.61, indicating good agreement. Enrolment was therefore
closed with 441 allocated to each study group.
The primary analyses of outcomes were based on intention-
to-treat (including those men who were alive but did not
respond to follow-up as having the same maximum
walking distance as at baseline) using the chi-square test
and α = 0.05 to compare proportions of men whose
category of self-reported maximum walking distance had
improved, become worse or stayed the same. These were
supported by comparisons of proportions in each category
of maximum walking distance at baseline and each follow-
up point. Additional analyses concerned differences
between the groups in quality of life (t-test) and in smoking
status and self-reported physical activity at two and 12
months post-enrolment. At each follow-up point, response
fractions were adjusted for men who had died or for whom
letters were returned and no new address could be found.
Ethical considerations With permission from the
Committee for Human Rights at The University of Western
Australia, the study was conducted as a double-blind
randomised controlled trial with neither group of men
made aware that they had been enrolled in an experiment.
Staff members who coded follow-up questionnaires were
also blind to the group allocation of individual men.
Results
Of the 928 men identified with early peripheral arterial
disease at screening, 41 were ineligible for inclusion in the
randomised controlled trial on the basis of aortic size and
five were not randomised due to late return of the
questionnaire, leaving 882 eligible men. Equal numbers of
participants were allocated to the usual care (n = 441) and
intervention (n = 441) groups. Of the 406 individual
general practitioners, 123 (30%) had participants in both
the usual care and intervention groups. However, as the
diagnosis of early peripheral arterial disease for men in the
usual care group was not communicated to the doctor in
correspondence from the screening clinic, little
contamination between study groups was expected.
Table 1 shows that the two study groups were well balanced
at recruitment in terms of factors related to the
intervention, pattern of intermittent claudication and
significant cardiovascular co-morbidity. The prevalence of
diabetes mellitus was somewhat higher in men allocated to
usual care (χ2 = 3.90, df = 1, p = 0.06), but the two groups
were well matched in terms of age, ankle:brachial index of
systolic blood pressure, systolic and diastolic blood
pressure, and body mass index (all p > 0.35 on t-test), place
of birth and level of education.
The adjusted response fraction at two months was 84.9%
(see Table 2). At this follow-up, there were no statistically
significant differences between the study groups in
smoking status, any of three different measures of physical
activity, membership of an exercise group, self-reported
maximum walking distance or health-related quality of life
(Table 3). However, among those who smoked at
enrolment, more men allocated to the intervention group
had given up smoking, and the frequencies of walking for
recreation and of membership of an exercise program were
somewhat higher in the intervention group. These modest
differences probably reflect the long lead time involved in
consulting the general practitioner and undergoing an
initial assessment by the community physiotherapist.
The adjusted response fraction at 12 months was 85%
(Table 2). By this time, there was a highly significant
difference in membership of an exercise class (17%
intervention, 2% usual care, p < 0.001; Table 4). At 12
months more men in the intervention group had improved
their maximum walking distance (23% vs 15%; χ2 = 9.74,
df = 2, p = 0.008), and significant differences were also
apparent when the analyses were limited to men who
completed and returned questionnaires (Table 4), or when
overall patterns of maximum walking distance at baseline
and follow-up were compared (Table 5). In addition,
significantly more men in the intervention group reported
walking at least three times weekly for recreation (34% vs
25%, p = 0.01) and that their level of physical activity in the
preceding two months had been greater than had been usual
for them (11% vs 6%, p = 0.03; Table 4). More men in the
intervention than in the usual care group claimed to have
given up smoking although this did not reach statistical
significance. The two groups did not differ significantly
with regard to intermittent claudication and their scores on
the Index of Health Related Quality of Life were also
similar.
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Table 5. Categories of maximum walking distance at
follow-up.
Factor and Usual care Intervention p
category % %
2 months n = 348 n = 378 0.19
Less than 
100 yards 11.2 15.7
100 to 440 yards 29.4 26.6
Greater than 
440 yards  31.2 33.6
Pain-free walking 28.2 24.1
12 months n = 336 n = 361 0.01
Less than 
100 yards 15.3 8.2
100 to 440 yards 21.5 27.6
Greater than 
440 yards 24.5 23.0
Pain-free walking 38.7 41.2
Discussion
Using a double blind, randomised controlled design, we
have demonstrated that a simple intervention for early
peripheral arterial disease based on increased physical
activity and cessation of smoking results in a greater
maximum walking distance 12 months later. Despite some
concern that asking elderly men to change their lifestyle
and behaviour might have an adverse psychological effect,
we were reassured to see no between-group difference in
health-related quality of life at follow-up. We deliberately
designed our study to test the effectiveness of the
intervention in the setting of everyday community practice
rather than its efficacy under ideal conditions. Because of
its imperfect specificity, use of the Edinburgh Claudication
Questionnaire (Leng and Fowkes 1992) as a screening
instrument almost certainly means that we included men
whose pain on walking was not due to peripheral arterial
disease and who were therefore less likely to respond to our
intervention. Similarly, enrolling some men on the basis of
the ankle:brachial index of systolic blood pressure will
have meant that a proportion of participants in the study
had no intermittent claudication at baseline and thus less
possibility for improvement in maximum walking distance.
An intention-to-treat analysis is also inherently
conservative. 
Even though each of these features of our design made it
more difficult to disprove our null hypothesis, a significant
effect of the intervention was still apparent. The blinding of
participants to the experimental protocol and the care taken
in the follow-up phases to avoid responses perceived as
desirable add to the confidence in our results. Our
validation of self-reported maximum walking distance
indicated good agreement with objectively measured
distance. In addition, there is internal consistency between
several different measures of physical activity at 12
months, and the impact of the intervention on smoking is
consistent with that reported from a systematic review of
the impact of anti-smoking advice from medical
practitioners (Law and Tang 1995). Moreover, our overall
findings are consistent with well-established patterns of
management of more severe peripheral arterial disease
evident in a Cochrane Review (Leng et al 1997).
Peripheral arterial disease affects up to one in every nine
elderly men in Perth (Fowler et al 2002), which probably
reflects, at least in part, the long legacy of high levels of
smoking in generations born before 1935 (Hyndman et al
1991). Despite later cohorts smoking less, the rapid growth
of the elderly population and the increasing incidence of
diabetes that will follow the steady rise in average BMI
currently seen in Australia (National Health and Medical
Research Council 1997) mean that absolute numbers of
cases of peripheral arterial disease will not fall rapidly.
While few of these patients will ever come to surgical
intervention, a sizeable proportion will experience
worsening claudication (Leng et al 1996). 
There have been a large number of studies of the role of
exercise in symptomatic claudication. A recent review
(Chong et al 2000) identified 27 such studies: only one
study had more than 50 cases; only nine studies, involving
a total of 294 patients, had follow-up at six months; and
only one study of 25 patients extended to 12 months post-
intervention. Although the majority of these reports
indicate some benefit from exercise in claudication,
individual studies were limited by small sample sizes. 
Most previous studies of exercise and claudication have
focused on patients referred with symptoms severe enough
to warrant surgical intervention. The majority of
participants in our trial had evidence of early peripheral
arterial disease but were not candidates for invasive
management. We have shown that this early, and potentially
progressive, disability can be limited in older men by a
combination of simple and safe interventions that are
readily available in the community. While statistically
significant, the between-group differences evident after 12
months were modest, but being able to walk up to 440
yards is clinically and functionally important, as it means
the individual would be able to leave home, walk to a bus
stop and use public transport to undertake such activities as
shopping or visiting a general practitioner. Although
beyond the scope of the present study, it is possible that in
addition to being able to walk further, the intervention we
employed may have other cardiovascular benefits (Fowkes
at al 1998, Shephard and Balady 1999). 
Conclusion
A combination of simple and safe interventions that are
readily available in the community through
physiotherapists and general practitioners has the potential
to improve early peripheral arterial disease.
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